You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

Table 1.  

Cognitive Deficits Associated with Essential Tremor34

Box 1.  

Classic Concept of Essential Tremor

Box 2.  

Essential Tremor: New Findings

Box 3.  

Cognition in Patients with Essential Tremor

CME

Essential Tremor -- A Neurodegenerative Disorder Associated With Cognitive Defects?

  • Authors: Félix Bermejo-Pareja, MD, PhD
  • CME Released: 4/12/2011
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 4/12/2012
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care clinicians, family practitioners, and other health professionals caring for patients with benign essential tremor.

The goal of this activity is to review the evidence that essential tremor may be a slowly progressive neurodegenerative disorder.

Upon completion of this activity, participants will be able to:

  1. Describe cognitive and mood abnormalities in patients with essential tremor on the basis of review findings
  2. Describe evidence for cerebellar and other pathology in patients with essential tremor on the basis of review findings
  3. Describe recommended diagnostic workup in patients with essential tremor on the basis of review findings


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Félix Bermejo-Pareja, MD, PhD

    Department of Neurology, University Hospital "Doce de Octubre," Madrid, Spain

    Disclosures

    Disclosure: Félix Bermejo-Pareja, MD, PhD, has disclosed no relevant financial relationships.

Editor(s)

  • Heather Wood

    Chief Editor, Nature Reviews Neurology

    Disclosures

    Disclosure: Heather Wood has disclosed no relevant financial relationships.

CME Author(s)

  • Laurie Barclay, MD

    Freelance writer and reviewer, Medscape, LLC

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

  • Sarah Fleischman

    CME Program Manager, Medscape, LLC

    Disclosures

    Disclosure: Sarah Fleischman has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Nature Publishing Group. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. MedscapeCME encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME

Essential Tremor -- A Neurodegenerative Disorder Associated With Cognitive Defects?

Authors: Félix Bermejo-Pareja, MD, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 4/12/2011

Valid for credit through: 4/12/2012

processing....

Abstract and Introduction

Abstract

In the past decade, the hypothesis that essential tremor is a monosymptomatic tremorogenic disorder has been questioned. New clinical, neuroimaging, electrophysiological and pathological studies indicate that essential tremor is associated with subtle neurological deficits and could be considered a slowly progressive neurodegenerative disorder. The aim of this Review is to describe the nonmotor neurological symptoms that are commonly associated with essential tremor, and highlight the cognitive deficits associated with this condition. Several clinical studies have demonstrated that essential tremor is associated with mild deficits in attention, executive functions, memory and, possibly, other cognitive processes. Population-based surveys have confirmed that dysfunction in these cognitive domains affects patients both with severe and mild essential tremor. Clinical studies have also indicated that cognitive deficits associated with essential tremor are progressive and that patients with this condition have an increased risk of dementia. Mood and cognitive deficits commonly observed in patients with essential tremor are similar to symptoms of cerebellar cognitive affective syndrome. Further evidence is required from prospective studies to support the interpretation that essential tremor is a slowly progressive neurodegenerative disorder.

Introduction

In the late 20th century, most of the early studies of essential tremor did not provide evidence that this disorder was associated with any cognitive deficits,[1-5] although in one study conducted by Rajput et al. "psychoneuroses" were reported in 16% of cases.[6] In fact, most of the clinical series and neurological texts published during this time period described essential tremor as a monosymptomatic, slowly progressive, benign movement disorder ( Box 1 ).[7-9] Furthermore, research conducted during this period indicated that this condition was frequently familial in nature, infrequently associated with incapacitating tremor, and associated with disturbances in tandem gait ataxia in chronic cases.[1,3,5,10,11] Although the etiology of essential tremor is still not fully understood, the condition is considered to be a functional (tremorogenic) disorder.[2,11,12] Further research has showed that essential tremor is association with other movement disorders, such as Parkinson disease (PD), dystonia and myoclonus,[4,5] but the Movement Disorders Society has defined essential tremor as a separate entity from these neurological disorders and secondary causes of tremor.[13]

Over the past decade, contemporary, multidisciplinary studies that have evaluated patients with essential tremor[14] have shown that these patients typically experience mild neurological[12,15-24] and cognitive deficits,[25-35] and indicate that patients with essential tremor have an increased risk of dementia.[35-37] Neuropsychiatric manifestations such as mood disorders have also been associated with essential tremor.[38-40] These findings, along with pathophysiological observations showing that patients with essential tremor have substantially more cerebellar atrophy than controls, indicate that essential tremor is associated with damage to the cerebellum or its connectivity to other brain regions.[41-44] The fact that essential tremor is associated with pathophysiological changes within the brain, cognitive and neuropsychiatric disturbances, and other neurodegenerative disorders such as PD,[44] and typically worsens with age, has led several authors to suggest that it could be a neurodegenerative disorder.[45-47] This article provides an overview of the nonmotor and cognitive aspects of essential tremor, and describes but does not analyze in depth neuropsychiatric aspects that are associated with this condition.